Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06036758 · ClinicalTrials.gov registry record
VIDAS® NEPHROCLEAR Diagnostic Accuracy Study
A clinical trial, sponsored by BioMérieux.
- Completed
- Registry status
- 477
- Enrollment target
NCT06036758 is a clinical trial that has completed, run by BioMérieux. The registered enrollment target is 477 participants.
The verdict
NCT06036758 has completed, sponsored by BioMérieux.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
This is a multi-center sample analysis study in which urine samples previously collected from persons with Stage 2 or Stage 3 Acute Kidney Injury (AKI), will be tested in order to validate the VIDAS® NEPHROCLEAR™ CCL14 Test
Interventions
- DIAGNOSTIC_TEST VIDAS® NEPHROCLEAR™ CCL14 Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2023-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06036758
The ClinicalTrials.gov registry entry for NCT06036758 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMérieux, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VIDAS® NEPHROCLEAR™ CCL14 Test is the first listed.
NCT06036758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06036758 about?
NCT06036758 is a clinical study titled "VIDAS® NEPHROCLEAR Diagnostic Accuracy Study". This is a multi-center sample analysis study in which urine samples previously collected from persons with Stage 2 or Stage 3 Acute Kidney Injury (AKI), will be tested in order to validate the VIDAS® NEPHROCLEAR™ CCL14 Test
What is the current status of trial NCT06036758?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2023-07-17. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT06036758?
The interventions under investigation include: VIDAS® NEPHROCLEAR™ CCL14 Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06036758?
This trial is sponsored by BioMérieux, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.